Autolus Therapeutics (AUTL)

• Market cap: $431M
• 1 day: 7.28%
• 5 days: 0%
• 1 month: 10.96%
• 3 months: 8.72%
• 6 months: 18.25%
• Year to date: -13.37%
• 1 year: -16.49%
• 5 years: -74.45%
• 10 years: -93.52%
• Sector: Healthcare
• Industry: Biotechnology

About: Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Employees: 647